ClinicalTrials.gov record
Completed Phase 2 Interventional Accepts healthy volunteers Results available

A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers

ClinicalTrials.gov ID: NCT01049035

Public ClinicalTrials.gov record NCT01049035. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 10:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine Administered in Infants and Toddlers

Study identification

NCT ID
NCT01049035
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi Pasteur, a Sanofi Company
Industry
Enrollment
580 participants

Conditions and interventions

Interventions

  • Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine Combined (DTaP-IPV/Hib combined) Biological
  • Hepatitis B Vaccine Biological
  • M-M-RII-Measles, Mumps, and Rubella Virus Vaccine Live Biological
  • Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) Biological
  • Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein) Biological
  • Quadrivalent Meningococcal Polysaccharide (A, C, Y, and W-135) Tetanus Protein Conjugate Biological
  • Rotavirus Vaccine Biological
  • Varicella Virus Vaccine Live Biological

Biological

Eligibility (public fields only)

Age range
42 Days to 365 Days
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 15, 2009
Primary completion
Feb 12, 2012
Completion
Feb 12, 2012
Last update posted
Mar 27, 2022

2009 – 2012

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
23
Facility City State ZIP Site status
Not listed Birmingham Alabama 35205
Not listed Tuscaloosa Alabama 35406
Not listed Jonesboro Arkansas 72401
Not listed Little Rock Arkansas 72205
Not listed Fountain Valley California 92708
Not listed Huntington Beach California 92647
Not listed Marietta Georgia 30062
Not listed Woodstock Georgia 30189
Not listed Bardstown Kentucky 40004
Not listed Crestview Hills Kentucky 41017
Not listed Louisville Kentucky 40207
Not listed Louisville Kentucky 40291
Not listed Bossier City Louisiana 71111
Not listed Clyde North Carolina 28721
Not listed Cleveland Ohio 44121
Not listed Pittsburgh Pennsylvania 15241
Not listed Barnwell South Carolina 29812
Not listed Clarksville Tennessee 37043
Not listed Fort Worth Texas 76107
Not listed Layton Utah 84041
Not listed Orem Utah 84057
Not listed Springville Utah 84663
Not listed Midlothian Virginia 23113
Not listed Spokane Washington 99202
Not listed Spokane Washington 99218

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01049035, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 27, 2022 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01049035 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →